Avalanche Treasury Corp Receives Nasdaq Notices Over Low Share Price

What Happened
Avalanche Treasury Corp (ticker: AVAT) announced in an 8‑K filed August 7, 2026 that on August 6, 2026 it received two deficiency letters from the Nasdaq Listing Qualifications Department. Nasdaq notified the company that (1) its Class A common stock’s closing bid has been below the $1.00 minimum for 33 consecutive business days and (2) its market value of listed securities (MVLS) has been below the $35 million threshold for 33 consecutive business days. The stock continues to trade on The Nasdaq Capital Market while the company has until February 2, 2027 (a 180‑day compliance period) to regain compliance. The company said it will monitor the situation and may consider options such as a reverse stock split.

Key Details

• Date of notices: August 6, 2026; 8‑K filed August 7, 2026.
• Minimum bid price deficiency: closing bid below $1.00 for 33 consecutive business days; 180‑day cure period ending February 2, 2027; must close ≥ $1.00 for 10 consecutive business days to regain compliance.
• MVLS deficiency: MVLS below $35 million for 33 consecutive business days; same February 2, 2027 deadline; must have MVLS ≥ $35 million for 10 consecutive business days to regain compliance.
• If not cured, the company could receive delisting notice but may be eligible for a second 180‑day period (if other listing standards are met) or appeal any delisting determination; no assurance of cure.

Why It Matters
Nasdaq deficiency notices signal a real risk of future delisting if AVAT does not restore its share price and market value within the cure periods. Delisting can reduce liquidity, limit investor access to the stock, and negatively affect the share price and investor returns. The company has options (for example, a reverse stock split) but provided no guarantee it will regain compliance; investors should monitor filings and trading updates through the cure period.